Squamous Cell Carcinoma of Anal Canal
Oncology
Prevalence
0.5 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| retifanlimab | Incyte Corp. (INCY) |
Frequently asked questions
How many drugs are in development for Squamous Cell Carcinoma of Anal Canal?
BioSniper tracks 1 drug in development for Squamous Cell Carcinoma of Anal Canal across 1 company.
How many clinical trials target Squamous Cell Carcinoma of Anal Canal?
There are 1 clinical trial targeting Squamous Cell Carcinoma of Anal Canal tracked by BioSniper.
What is the prevalence of Squamous Cell Carcinoma of Anal Canal?
The estimated prevalence of Squamous Cell Carcinoma of Anal Canal is approximately 0.5 per 100,000 population.
Deep-dive into Squamous Cell Carcinoma of Anal Canal
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis